The Oncology Institute, Inc. TOI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $545.76M+35.4% | $502.73M+27.8% | $461.04M+21.7% | $424.38M+17.5% | $403.15M+17.6% | ||
| $108.41M+3.5% | $105.57M-2.1% | $102.39M-7.8% | $103.79M-7.8% | $104.75M-7.7% | ||
| $578.45M+27.1% | $538.81M+18.8% | $502.14M+13.5% | $471.28M+11.0% | $455.21M+12.4% | ||
| -$32.69M+37.2% | -$36.08M+40.0% | -$41.11M+35.2% | -$46.9M+26.2% | -$52.06M+16.2% | ||
| -6%+6.9pp | -7.2%+8.1pp | -8.9%+7.8pp | -11.1%+6.5pp | -12.9%+5.2pp | ||
| $7.64M-31.1% | $11.28M+50.4% | $10.53M+27.3% | $10.83M+38.9% | $11.08M+51.4% | ||
| -$10.96M+10.9% | -$24.65M-442% | -$25.31M-258% | -$19.12M-134% | -$12.3M-12.7% | ||
| -$43.64M+32.2% | -$60.74M+6.1% | -$66.41M+5.9% | -$66.02M+7.9% | -$64.36M+11.9% | ||
| -$131K— | -$131K— | -$131K+58.3% | -$131K+26.8% | $0+100% | ||
| -$43.51M+32.4% | -$60.61M+6.3% | -$66.28M+5.6% | -$65.89M+7.9% | -$64.36M+11.8% | ||
| -8%+8.0pp | -12.1%+4.4pp | -14.4%+4.2pp | -15.5%+4.3pp | -16%+5.3pp | ||
| -$0.36+49.3% | -$0.55+23.6% | -$0.65+16.7% | -$0.69+12.7% | -$0.71+12.3% | ||
| -$25.91M+43.0% | -$29.14M+45.9% | -$34.09M+40.5% | -$40.04M+30.1% | -$45.48M+18.8% | ||
| -4.7%+6.5pp | -5.8%+7.9pp | -7.4%+7.7pp | -9.4%+6.4pp | -11.3%+5.1pp | ||
| -$32.69M+37.2% | -$36.08M+40.0% | -$41.11M+35.2% | -$46.9M+26.2% | -$52.06M+16.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is The Oncology Institute, Inc.'s revenue?
- The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.
- Is The Oncology Institute, Inc. profitable?
- The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.
- What is The Oncology Institute, Inc.'s earnings per share?
- The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
- Where does The Oncology Institute, Inc.'s income statement data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
